X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
47
PharmaCompass offers a list of Fingolimod Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fingolimod Hydrochloride manufacturer or Fingolimod Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fingolimod Hydrochloride manufacturer or Fingolimod Hydrochloride supplier.
PharmaCompass also assists you with knowing the Fingolimod Hydrochloride API Price utilized in the formulation of products. Fingolimod Hydrochloride API Price is not always fixed or binding as the Fingolimod Hydrochloride Price is obtained through a variety of data sources. The Fingolimod Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fingolimod HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fingolimod HCl, including repackagers and relabelers. The FDA regulates Fingolimod HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fingolimod HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fingolimod HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fingolimod HCl supplier is an individual or a company that provides Fingolimod HCl active pharmaceutical ingredient (API) or Fingolimod HCl finished formulations upon request. The Fingolimod HCl suppliers may include Fingolimod HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Fingolimod HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fingolimod HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Fingolimod HCl active pharmaceutical ingredient (API) in detail. Different forms of Fingolimod HCl DMFs exist exist since differing nations have different regulations, such as Fingolimod HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fingolimod HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Fingolimod HCl USDMF includes data on Fingolimod HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fingolimod HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fingolimod HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fingolimod HCl Drug Master File in Japan (Fingolimod HCl JDMF) empowers Fingolimod HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fingolimod HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Fingolimod HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fingolimod HCl suppliers with JDMF on PharmaCompass.
A Fingolimod HCl CEP of the European Pharmacopoeia monograph is often referred to as a Fingolimod HCl Certificate of Suitability (COS). The purpose of a Fingolimod HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fingolimod HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fingolimod HCl to their clients by showing that a Fingolimod HCl CEP has been issued for it. The manufacturer submits a Fingolimod HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fingolimod HCl CEP holder for the record. Additionally, the data presented in the Fingolimod HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fingolimod HCl DMF.
A Fingolimod HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fingolimod HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fingolimod HCl suppliers with CEP (COS) on PharmaCompass.
A Fingolimod HCl written confirmation (Fingolimod HCl WC) is an official document issued by a regulatory agency to a Fingolimod HCl manufacturer, verifying that the manufacturing facility of a Fingolimod HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fingolimod HCl APIs or Fingolimod HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Fingolimod HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Fingolimod HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fingolimod HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fingolimod HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fingolimod HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fingolimod HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fingolimod HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fingolimod HCl suppliers with NDC on PharmaCompass.
Fingolimod HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fingolimod HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fingolimod HCl GMP manufacturer or Fingolimod HCl GMP API supplier for your needs.
A Fingolimod HCl CoA (Certificate of Analysis) is a formal document that attests to Fingolimod HCl's compliance with Fingolimod HCl specifications and serves as a tool for batch-level quality control.
Fingolimod HCl CoA mostly includes findings from lab analyses of a specific batch. For each Fingolimod HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fingolimod HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Fingolimod HCl EP), Fingolimod HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fingolimod HCl USP).
Market Place
